Hospital
Terre Haute Regional Hospital, L.P.
Terre Haute Regional Hospital, L.P. was paid $16.65M by Medicaid between Jan 2018 and Dec 2024, across 105 billing codes. Its largest line is 99283, emergency room visit (moderate) — 25% of everything it billed.
33Billing provider infoTERRE HAUTE REGIONAL HOSPITAL, L.P.
TERRE HAUTE, IN 47802
TERRE HAUTE, IN 47802
33aNPI1073550133assigned 05/31/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$16.65M
24GClaims373,629
24DCodes billed105
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Indiana
Rank by total paid#24 of 69
Median peer was paid$9.76M
This provider vs. median1.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 44,664 | $762K | |
| 2019 | 46,118 | $2.05M | |
| 2020 | 37,562 | $1.69M | |
| 2021 | 61,222 | $2.63M | |
| 2022 | 78,729 | $3.66M | |
| 2023 | 60,595 | $3.44M | |
| 2024incomplete | 44,739 | $2.42M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 25% | 32,839 | 25,506 | $4.22M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 21% | 32,292 | 22,085 | $3.49M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 7.5% | 3,983 | 2,531 | $1.25M |
| 71045 | Radiologic examination, chest; single view | 7.1% | 13,255 | 8,391 | $1.17M |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 6.3% | 21,209 | 14,350 | $1.04M |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 6.0% | 2,823 | 2,091 | $1.00M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 4.5% | 5,341 | 4,398 | $753K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 3.4% | 13,487 | 8,884 | $560K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.8% | 3,614 | 2,368 | $294K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1.6% | 5,335 | 3,815 | $271K |
| J7030 | Infusion, normal saline solution , 1000 cc | 1.5% | 10,411 | 6,749 | $250K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.4% | 4,608 | 3,079 | $228K |
93 more codes
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.1% | 6,105 | $178K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 1.0% | 1,077 | $173K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 6,754 | $143K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 370 | $137K |
| 85027 | <1% | 46,718 | $135K | |
| 80053 | Comprehensive metabolic panel | <1% | 27,818 | $128K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 792 | $107K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 6,984 | $103K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 2,063 | $97K |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 2,718 | $75K |
| 99285 | Emergency room visit (most serious) | <1% | 747 | $73K |
| 11043 | <1% | 286 | $69K | |
| 84484 | <1% | 13,765 | $66K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 444 | $66K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 13,379 | $49K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 993 | $46K |
| 87400 | <1% | 3,065 | $42K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 1,584 | $39K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 321 | $29K |
| G0378 | Hospital observation service, per hour | <1% | 263 | $27K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 180 | $26K |
| 82077 | <1% | 2,824 | $25K | |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 346 | $22K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 467 | $21K |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 584 | $21K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 164 | $20K |
| 81025 | <1% | 3,483 | $18K | |
| 81001 | <1% | 12,033 | $18K | |
| 83690 | <1% | 6,497 | $18K | |
| 87070 | <1% | 3,183 | $16K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,546 | $14K |
| 87430 | <1% | 1,196 | $13K | |
| 80143 | <1% | 1,362 | $13K | |
| 80179 | <1% | 1,361 | $13K | |
| 83735 | <1% | 4,074 | $12K | |
| 83880 | <1% | 616 | $8K | |
| 81003 | <1% | 6,006 | $7K | |
| 80076 | <1% | 2,181 | $7K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 2,128 | $7K |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,990 | $6K |
| 85379 | <1% | 1,279 | $6K | |
| 43249 | <1% | 205 | $5K | |
| 85610 | <1% | 2,501 | $4K | |
| 84703 | <1% | 912 | $4K | |
| 43248 | <1% | 32 | $3K | |
| 87040 | <1% | 346 | $2K | |
| 83605 | <1% | 442 | $2K | |
| 87420 | <1% | 184 | $2K | |
| 86140 | <1% | 623 | $2K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 242 | $2K |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 56 | $1K |
| 80061 | Lipid panel | <1% | 188 | $1K |
| 85730 | <1% | 402 | $1K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 12 | $831.36 |
| 73610 | <1% | 15 | $693.43 | |
| 82150 | <1% | 224 | $673.92 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 47 | $494.02 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 43 | $465.05 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 15 | $369.86 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 15 | $369.86 |
| 82465 | <1% | 74 | $324.81 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 14 | $295.62 |
| 87077 | <1% | 52 | $142.94 | |
| 83655 | <1% | 12 | $141.00 | |
| 83516 | <1% | 13 | $108.25 | |
| 82784 | <1% | 16 | $87.37 | |
| 84100 | <1% | 22 | $84.84 | |
| 87075 | <1% | 52 | $65.84 | |
| J3490 | Unclassified drugs | <1% | 109 | $45.88 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 5,624 | $38.92 |
| 87205 | <1% | 52 | $37.88 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 5,547 | $28.97 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 9,272 | $6.34 |
| J7050 | Infusion, normal saline solution, 250 cc | 0% | 2,041 | $0.00 |
| J1790 | Injection, droperidol, up to 5 mg | 0% | 54 | $0.00 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 750 | $0.00 |
| C1726 | Catheter, balloon dilatation, non-vascular | 0% | 292 | $0.00 |
| A9270 | Non-covered item or service | 0% | 293 | $0.00 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 0% | 154 | $0.00 |
| J1170 | Injection, hydromorphone, up to 4 mg | 0% | 44 | $0.00 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 0% | 42 | $0.00 |
| J8540 | Dexamethasone, oral, 0.25 mg | 0% | 65 | $0.00 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 131 | $0.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 45 | $0.00 |
| C1769 | Guide wire | 0% | 19 | $0.00 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 0% | 21 | $0.00 |
| S0119 | Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) | 0% | 83 | $0.00 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 0% | 1,619 | $0.00 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 0% | 511 | $0.00 |
| G1003 | Clinical decision support mechanism medicalis, as defined by the medicare appropriate use criteria program | 0% | 76 | $0.00 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 0% | 46 | $0.00 |
| 96523 | 0% | 19 | $0.00 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | 0% | 18 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCHILSON, JEFF (CFO)